CUAMC
ADMA icon

China Universal Asset Management Company’s ADMA Biologics ADMA Stock Holding History

China Universal Asset Management Company’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
36,887
-5,376
-13% -$49K 0.02% 317
2026
Q1 		$381K Buy
42,263
+3,481
+9% +$54.9K 0.03% 286
2025
Q4 		$707K Sell
38,782
-3,046
-7% -$51.3K 0.05% 220
2025
Q3 		$613K Sell
41,828
-6,121
-13% -$105K 0.05% 225
2025
Q2 		$873K Buy
47,949
+533
+1% +$10.9K 0.08% 183
2025
Q1 		$941K Sell
47,416
-2,707
-5% -$46.8K 0.09% 194
2024
Q4 		$860K Buy
50,123
+5,294
+12% +$99.6K 0.08% 180
2024
Q3 		$896K Buy
44,829
+17,595
+65% +$274K 0.1% 146
2024
Q2 		$304K Sell
27,234
-16,636
-38% -$140K 0.04% 189
2024
Q1 		$290K Buy
43,870
+17,728
+68% +$96.9K 0.04% 246
2023
Q4 		$118K Buy
26,142
+20,378
+354% +$75.4K 0.02% 262
2023
Q3 		$20.6K Buy
5,764
+2,851
+98% +$11K 0.01% 294
2023
Q2 		$10.7K Sell
2,913
-80
-3% -$297 ﹤0.01% 313
2023
Q1 		$9.91K Buy
2,993
+994
+50% +$3.44K ﹤0.01% 294
2022
Q4 		$7.76K Buy
1,999
+161
+9% +$497 ﹤0.01% 249
2022
Q3 		$4K Buy
+1,838
New +$4.41K ﹤0.01% 285

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

China Universal Asset Management Company's ADMA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its ADMA Biologics (ADMA) stake by 13% in Q2 2026, selling an estimated $49K and leaving 36,887 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #317.

China Universal Asset Management Company first reported a position in ADMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $941K in Q1 2025. 191 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • China Universal Asset Management Company held 36,887 shares of ADMA Biologics worth $309K as of Q2 2026.
  • China Universal Asset Management Company sold 5,376 ADMA Biologics shares in Q2 2026, an estimated $49K.
  • ADMA Biologics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #317 holding.
  • China Universal Asset Management Company first reported a position in ADMA Biologics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's ADMA Biologics position peaked at $941K in Q1 2025.
  • 191 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.